Tocilizumab in patients with severe COVID-19: a retrospective cohort study
作者： Giovanni Guaraldi , Marianna Meschiari , Alessandro Cozzi-Lepri , Jovana Milic , Roberto Tonelli
DOI: 10.1016/S2665-9913(20)30173-9
关键词: Cohort study 、 Pneumonia 、 Internal medicine 、 Mechanical ventilation 、 Tocilizumab 、 Clinical endpoint 、 Retrospective cohort study 、 Medicine 、 Low molecular weight heparin 、 Azithromycin
摘要: Background No therapy is approved for COVID-19 pneumonia. The aim of this study was to assess the role of tocilizumab in reducing the risk of invasive mechanical ventilation and …
elsevier.com
sci-hub.st 参考文章(36)
Arthur Kavanaugh, Interleukin-6 inhibitors in the treatment of rheumatoid arthritis Therapeutics and Clinical Risk Management. ,vol. 4, pp. 767- 775 ,(2008) , 10.2147/TCRM.S3470
Miroslav Dostalek, Iain Gardner, Brian M. Gurbaxani, Rachel H. Rose, Manoranjenni Chetty, Pharmacokinetics, Pharmacodynamics and Physiologically-Based Pharmacokinetic Modelling of Monoclonal Antibodies Clinical Pharmacokinectics. ,vol. 52, pp. 83- 124 ,(2013) , 10.1007/S40262-012-0027-4
Mary E. Charlson, Peter Pompei, Kathy L. Ales, C.Ronald MacKenzie, A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation☆ Journal of Chronic Diseases. ,vol. 40, pp. 373- 383 ,(1987) , 10.1016/0021-9681(87)90171-8
Xiaoping Zhang, Angela Georgy, Lucy Rowell, Pharmacokinetics and pharmacodynamics of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, following single-dose administration by subcutaneous and intravenous routes to healthy subjects. principles and practice of constraint programming. ,vol. 51, pp. 443- 455 ,(2013) , 10.5414/CP201819
Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) Consortium, None, The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. The Lancet. ,vol. 379, pp. 1214- 1224 ,(2012) , 10.1016/S0140-6736(12)60110-X
Katherine L. Gill, Krishna K. Machavaram, Rachel H. Rose, Manoranjenni Chetty, Potential Sources of Inter-Subject Variability in Monoclonal Antibody Pharmacokinetics Clinical Pharmacokinetics. ,vol. 55, pp. 789- 805 ,(2016) , 10.1007/S40262-015-0361-4
A Craig Davidson, Stephen Banham, Mark Elliott, Daniel Kennedy, Colin Gelder, Alastair Glossop, Alistair Colin Church, Ben Creagh-Brown, James William Dodd, Tim Felton, Bernard Foëx, Leigh Mansfield, Lynn McDonnell, Robert Parker, Caroline Marie Patterson, Milind Sovani, Lynn Thomas, , BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults Thorax. ,vol. 71, ,(2016) , 10.1136/THORAXJNL-2015-208209
Richa Saroa, Aditi Jain, Sanjeev Palta, Anshu Palta, Sonu Sama, Satinder Gombar, Sequential organ failure assessment scoring and prediction of patient's outcome in Intensive Care Unit of a tertiary care hospital. Journal of Anaesthesiology Clinical Pharmacology. ,vol. 32, pp. 364- 368 ,(2016) , 10.4103/0970-9185.168165
John H Stone, Katie Tuckwell, Sophie Dimonaco, Micki Klearman, Martin Aringer, Daniel Blockmans, Elisabeth Brouwer, Maria C Cid, Bhaskar Dasgupta, Juergen Rech, Carlo Salvarani, Georg Schett, Hendrik Schulze-Koops, Robert Spiera, Sebastian H Unizony, Neil Collinson, None, Trial of Tocilizumab in Giant-Cell Arteritis. The New England Journal of Medicine. ,vol. 377, pp. 317- 328 ,(2017) , 10.1056/NEJMOA1613849
Lesley J. Scott, Tocilizumab: A Review in Rheumatoid Arthritis. Drugs. ,vol. 77, pp. 1865- 1879 ,(2017) , 10.1007/S40265-017-0829-7